Skip to main content
. 2022 Aug 17;13:904448. doi: 10.3389/fphar.2022.904448

FIGURE 8.

FIGURE 8

Chemotherapy drug sensitivity between the high- and low-risk group. (A) IC50 of Cisplatin. (B) IC50 of Methotrexate. (C) IC50 of MG-132. (D) IC50 of Paclitaxel. (E) IC50 of Doxorubicin.